International law firm Taylor Wessing has represented one of the investors in a USD 270 million Series A round of financing of BioNTech AG, a fully-integrated biotechnology company pioneering individualized cancer immunotherapy.

Legal advisors

Taylor Wessing: Dr. Norman Röchert and Marc-Oliver Kurth (Lead Partner, Partners, Berlin), Maria Weiers (Partner, Düsseldorf), Dr. Sebastian Beyer (Salary Partner, Frankfurt), Dr. Sebastian Klabunde (Senior Associate), Christian Ahrendt (Associate, both Berlin) (all Corporate, M&A an Capital Markets)